Get started
Author

Natalie E. Parks

Observed names: Natalie E Parks, Natalie Parks
OpenAlex ID: A5045183602
Dietary interventions for multiple sclerosis-related outcomes
2020 · Natalie E Parks, Caitlin S Jackson-Tarlton, et al. · Cochrane Database of Systematic Reviews · 95
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
2017 · Yong Guo, Stephen D. Weigand, et al. · Acta Neuropathologica · 84
PDF
Neuroradiologic manifestations of Erdheim-Chester disease
2018 · Natalie E. Parks, Gaurav Goyal, et al. · Neurology Clinical Practice · 61
Fatigue Impact Scale Demonstrates Greater Fatigue in Younger Stroke Survivors
2012 · Natalie E. Parks, Gail A. Eskes, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 56
PDF
NEDA treatment target? No evident disease activity as an actionable outcome in practice
2017 · Natalie E. Parks, Eoin P. Flanagan, et al. · Journal of the Neurological Sciences · 29
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection
2014 · Tim J Benstead, Colin H Chalk, et al. · Cochrane Database of Systematic Reviews · 19
Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas
2015 · Natalie E. Parks, Virender Bhan, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 16
PDF
Dysmetropsia and Cotard's syndrome due to migrainous infarction – or not?
2014 · Natalie E Parks, Heather B Rigby, et al. · Cephalalgia · 16
Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis
2021 · Natalie E Parks, Pantelis Andreou, et al. · Multiple Sclerosis and Related Disorders · 15
Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health
2024 · Dalia L. Rotstein, Mark S. Freedman, et al. · Multiple Sclerosis and Related Disorders · 10
PDF
Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder
2019 · Elia Sechi, Natalie E. Parks, et al. · Neurology · 10
PDF
Teaching Neuro Images : Neurodegeneration with brain iron accumulation in aceruloplasminemia
2013 · Natalie E. Parks, Robert A. Vandorpe, et al. · Neurology · 7
PDF
Population-based study of “no evident disease activity” in MS
2018 · Natalie E. Parks, Sean J. Pittock, et al. · Neurology Neuroimmunology & Neuroinflammation · 6
PDF
Charcot Ankle Arthropathy in CMT1A Exacerbated by Type 2 Diabetes Mellitus
2010 · Natalie E. Parks, Timothy J. Benstead · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 6
PDF
Comparison of vision-related quality of life in NMOSD and MOGAD
2025 · Adnan A. Gassan, Andrea Konig, et al. · Multiple Sclerosis and Related Disorders · 4
PDF
Maximizing Functional Independence in Sporadic Late Onset Nemaline Myopathy
2012 · Natalie E. Parks, Edwin Y. Hanada · PM&R · 4
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection
2013 · Tim J Benstead, Colin H Chalk, et al. · Cochrane Database of Systematic Reviews · 3
Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS
2026 · Elisa Saeedzadeh, Manav V. Vyas, et al. · Multiple Sclerosis and Related Disorders · 2
PDF
Demographic and Clinical Characteristics of Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder in Canadian Adults
2026 · Amirah I. Momen, Mark S. Freedman, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 1
Navigating the TOR of Multiple Sclerosis
2020 · Natalie E. Parks · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 1
PDF
Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab
2019 · Maximillian D. J. Fiander, Virender Bhan, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 1
PDF
Optimizing the management of AQP4 antibody-positive NMOSD: A Canadian consensus
2026 · Dalia L. Rotstein, Philippe Beauchemin, et al. · Multiple Sclerosis and Related Disorders
Bing-Neel Syndrome: An Atypical Complication of Waldenström Macroglobulinemia – A Case Report (P11-2.004)
2025 · Mehdi Belbraouet, Natalie Parks, et al. · Neurology
Pregnancy Outcomes and Disease Course in NMOSD and MOGAD in CANOPTICS (N2.002)
2023 · Laura Chu, Dalia Rotstein, et al. · Neurology
Teaching Neuro Images : Neurodegeneration with brain iron accumulation in aceruloplasminemia
2023 · Natalie E. Parks, Robert A. Vandorpe, et al. · Neurology
PDF
Works count: 33
Citation count: 445
H-index: 10
I10-index: 11
Year
Topic
Type